Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
60.905,57
0,18%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Artelo Biosciences Inc (ARTL) Artelo Biosciences Inc (ARTL) Notizie

ARTL

Artelo Biosciences (ARTL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ARTL
DataOraFonteTitoloSimboloCompagnia
10/05/202415:00GlobeNewswire Inc.Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14thNASDAQ:ARTLArtelo Biosciences Inc
23/04/202414:30GlobeNewswire Inc.Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer TherapyNASDAQ:ARTLArtelo Biosciences Inc
22/04/202414:30GlobeNewswire Inc.Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern TimeNASDAQ:ARTLArtelo Biosciences Inc
25/03/202413:00GlobeNewswire Inc.Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
12/03/202414:15GlobeNewswire Inc.Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation ChallengeNASDAQ:ARTLArtelo Biosciences Inc
23/01/202414:30GlobeNewswire Inc.Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral NeuropathyNASDAQ:ARTLArtelo Biosciences Inc
08/01/202414:30GlobeNewswire Inc.Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12NASDAQ:ARTLArtelo Biosciences Inc
05/12/202314:30GlobeNewswire Inc.Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in GermanyNASDAQ:ARTLArtelo Biosciences Inc
30/11/202315:00GlobeNewswire Inc.Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in GermanyNASDAQ:ARTLArtelo Biosciences Inc
13/11/202314:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARTLArtelo Biosciences Inc
13/11/202314:00GlobeNewswire Inc.Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
09/11/202315:00GlobeNewswire Inc.Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain CancersNASDAQ:ARTLArtelo Biosciences Inc
02/11/202313:30GlobeNewswire Inc.Artelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxiety and Depression at Neuroscience 2023NASDAQ:ARTLArtelo Biosciences Inc
04/10/202314:30GlobeNewswire Inc.Principal Investigator of Artelo’s CAReS Trial to Participate in Medical Expert Webinar Hosted by H.C. Wainwright to Discuss Current Development Strategies for Cancer-Related Anorexia and CachexiaNASDAQ:ARTLArtelo Biosciences Inc
13/09/202314:30GlobeNewswire Inc.Artelo Biosciences to Present at the 13th Congress of the European Pain Federation on September 20thNASDAQ:ARTLArtelo Biosciences Inc
07/09/202314:00GlobeNewswire Inc.Artelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12NASDAQ:ARTLArtelo Biosciences Inc
06/09/202315:00GlobeNewswire Inc.Artelo Biosciences to Present at the 6th Cannabinoid-Derived Drug Development Summit on September 12thNASDAQ:ARTLArtelo Biosciences Inc
05/09/202315:00GlobeNewswire Inc.Artelo Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 13thNASDAQ:ARTLArtelo Biosciences Inc
10/08/202314:00GlobeNewswire Inc.Artelo Biosciences Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
08/08/202322:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARTLArtelo Biosciences Inc
08/08/202322:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARTLArtelo Biosciences Inc
19/07/202315:00GlobeNewswire Inc.Artelo Biosciences to Present New Mechanism of Action Data on ART26.12 at the Gordon Research Conference on July 20, 2023NASDAQ:ARTLArtelo Biosciences Inc
17/07/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ARTLArtelo Biosciences Inc
10/07/202314:30GlobeNewswire Inc.Artelo Biosciences CEO to Participate in the Benzinga All Access Event on July 11NASDAQ:ARTLArtelo Biosciences Inc
07/07/202314:23Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:ARTLArtelo Biosciences Inc
06/07/202322:31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ARTLArtelo Biosciences Inc
28/06/202314:30GlobeNewswire Inc.Artelo Biosciences Announces Sponsorship of The William A. Devane Early Career Investigator Award at the 33rd Annual International Cannabinoid Research Society SymposiumNASDAQ:ARTLArtelo Biosciences Inc
27/06/202314:30GlobeNewswire Inc.Artelo Biosciences Announces Important New Data on ART26.12 Demonstrating Positive Effects in Multiple Models of Neuropathic Pain at the 33rd Annual International Cannabinoid Research Society SymposiumNASDAQ:ARTLArtelo Biosciences Inc
26/06/202314:30GlobeNewswire Inc.Artelo Biosciences Reports Superior Preclinical Pharmaceutical Properties and Efficacy of ART12.11 Compared to Cannabidiol (CBD) at the 33rd Annual International Cannabinoid Research Society SymposiumNASDAQ:ARTLArtelo Biosciences Inc
07/06/202314:30GlobeNewswire Inc.Artelo Biosciences Selected for Oral Presentation to Report Positive Research Findings on ART12.11 at the 33rd Annual International Cannabinoid Research Society SymposiumNASDAQ:ARTLArtelo Biosciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ARTL

La tua Cronologia

COIN
NEXETH
Nash Exchange NEX Token
BITMOT
984481
Campari Tf 4,71% Mg30 Ca...
LSE
0JDI
Ionis Pharmaceuticals
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network